MAM
ISEE

Meeder Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Meeder Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,204
Closed -$3.29K – 1729
2018
Q2 		$3.29K Sell
1,204
-607
-34% -$1.68K ﹤0.01% 1341
2018
Q1 		$5K Sell
1,811
-323
-15% -$936 ﹤0.01% 1246
2017
Q4 		$7K Sell
2,134
-3,800
-64% -$10.7K ﹤0.01% 1239
2017
Q3 		$17K Buy
5,934
+1,718
+41% +$4.64K ﹤0.01% 942
2017
Q2 		$11K Buy
4,216
+3,124
+286% +$8.51K ﹤0.01% 981
2017
Q1 		$4K Buy
1,092
+600
+122% +$2.54K ﹤0.01% 1199
2016
Q4 		$2K Buy
+492
New +$14.6K ﹤0.01% 942

Other funds holding ISEE

D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Meeder Asset Management's ISEE Position: Q3 2018 in Review

Meeder Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2018, closing a stake of 1,204 shares — an estimated $3.29K sold.

Meeder Asset Management first reported a position in ISEE in Q4 2016 and held it in 7 quarters. The position peaked at $17K in Q3 2017. 68 funds tracked by Wall St. Rank hold ISEE as of Q3 2018.

  • Meeder Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Meeder Asset Management sold 1,204 IVERIC bio, Inc. Common Stock shares in Q3 2018, an estimated $3.29K.
  • Meeder Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2016 and held it in 7 quarters.
  • Meeder Asset Management's IVERIC bio, Inc. Common Stock position peaked at $17K in Q3 2017.
  • 68 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2018.

Based on Meeder Asset Management's 13F filing for Q3 2018, filed 2 Nov 2018.